Occudo Quantitative Strategies’s Sempreon, Inc. Common Stock CASK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
+15,013
New +$273K 0.01% 626
2025
Q1
– Sell
-10,130
Closed -$399K – 814
2024
Q4
$399K Buy
+10,130
New +$551K 0.07% 363
2024
Q3
– Sell
-3,245
Closed -$241K – 908
2024
Q2
$241K Sell
3,245
-1
-0% -$78 0.04% 538
2024
Q1
$280K Sell
3,246
-21,329
-87% -$1.85M 0.05% 484
2023
Q4
$2.42M Buy
24,575
+20,229
+465% +$1.94M 0.33% 80
2023
Q3
$458K Buy
4,346
+853
+24% +$96.7K 0.06% 533
2023
Q2
$371K Buy
3,493
+64
+2% +$6.4K 0.04% 667
2023
Q1
$332K Buy
+3,429
New +$335K 0.03% 619

Other funds holding CASK

Occudo Quantitative Strategies's CASK Position: Q2 2026 in Review

Occudo Quantitative Strategies opened a new position in Sempreon, Inc. Common Stock (CASK) in Q2 2026: 15,013 shares worth $263K. The stake represents 0.01% of the portfolio and ranks #626 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in CASK as recently as Q4 2024.

Occudo Quantitative Strategies first reported a position in CASK in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.42M in Q4 2023. 151 funds tracked by Wall St. Rank hold CASK as of Q2 2026.

  • Occudo Quantitative Strategies held 15,013 shares of Sempreon, Inc. Common Stock worth $263K as of Q2 2026.
  • Sempreon, Inc. Common Stock was a new Occudo Quantitative Strategies position in Q2 2026.
  • Sempreon, Inc. Common Stock made up 0.01% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #626 holding.
  • Occudo Quantitative Strategies first reported a position in Sempreon, Inc. Common Stock in Q1 2023 and has held it in 8 quarters since.
  • Occudo Quantitative Strategies's Sempreon, Inc. Common Stock position peaked at $2.42M in Q4 2023.
  • 151 funds tracked by Wall St. Rank held Sempreon, Inc. Common Stock as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.